DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Sat, 17 May · 18:17 IST

Divi's Laboratories Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has uploaded the audio recording of its Q4 FY25 and full-year FY25 earnings conference call, held on May 17, 2025 at 3:00 PM IST, to its website under the Investors Relations section. The filing is made under SEBI Regulation 30, as a follow-up to the company's earlier intimation dated May 8, 2025. The actual contents of the earnings call are not summarized in this filing — only the web link is shared. Investors interested in management commentary on margins, guidance, or strategy would need to listen to the recording.

Likely market impact

This is a routine compliance disclosure with no direct impact on the stock price. Shareholders who want to understand management's views on FY26 outlook, margins, or capex should listen to the linked earnings call audio for detailed commentary.